ℹ️ Compiled from public regulatory records · Last regulator revision: November 5, 2025🚩 Report this page
Potassium Bitartrate
Active ingredient
Sold as Phexx · Phexxi · CEO-TWO
US FDA
- Drug class
- -
- Availability
- Prescription and OTC
- Routes
- Rectal, Vaginal
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 7
Overview
Potassium Bitartrate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | November 5, 2025 |
USUnited States· FDA
3 products
Uses
Uses for relief of occasional constipation this product generally produces a bowel movement in 5 to 30 minutes
How to take
Sources & citations
- [1]FDA DailyMed · 08670636-5795-4d… · revised November 5, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.